Skip to main content
. 2013 Feb 22;7:13–20. doi: 10.2174/1874306401307010013

Table 1.

Demographics and Baseline Characteristics for Pooled CAP Studies 308 and 313 (Modified Intention to Treat Population)

Characteristic Tigecycline(n = 424) Levofloxacin(n = 422) p-Value
Age, Years
  Mean 52.65 51.87 0.539
  SD 17.99 18.74
Male, n (%) 243 (57.3) 265 (62.8) 0.107
Specific Risk Factors, n (%)
  Aged ≥65 years 122 (28.8) 122 (28.9) 1.000
  Prior antibiotic failure 62 (14.6) 74 (17.5) 0.262
  Bacteremia 32 (7.5) 31 (7.3) 1.000
  Multilobar disease at baseline 125 (29.5) 106 (25.1) 0.165
  COPD 49 (11.6) 43 (10.2) 0.581
  Hypoxemia 106 (25.0) 113 (26.8) 0.583
  Renal insufficiency or BUN >19.6 mg/dL or urea >7 mmol/L 136 (32.1) 132 (31.3) 0.825
  Diabetes or glucose >13.9 mmol/L 56 (13.2) 61 (14.5) 0.620
  Alcohol abuse 35 (8.3) 33 (7.8) 0.899
  Altered mental status 9 (2.1) 9 (2.1) 1.000
  WBC count >30 x 109/L or <4 x 109/L 21 (5.0) 19 (4.5) 0.872
CURB-65 Score, n (%)
  Total score ≥2 122 (28.8) 124 (29.4) 0.880
CURB-65 Score Components
  Confusion (altered mental status from medical history) 9 (2.1) 9 (2.1) 1.000
  Urea >7 mmol/L (BUN >19.6 mg/dL) 129 (30.4) 125 (29.6) 0.822
  Respiratory rate ≥30 breaths/min 109 (25.7) 95 (22.5) 0.296
  Blood pressure <90 systolic or diastolic blood pressure ≤60 74 (17.5) 86 (20.4) 0.293
  Aged ≥65 years 122 (28.8) 122 (28.9) 1.000
Fine Score, n (%)
  Category III-V 197 (46.5) 199 (47.2) 0.890
Clinical Instability Criteria
At least 2 criteria (listed below), n (%) 336 (79.2) 333 (78.9) 0.933
  Oral temperature >37.8°C 381 (89.9) 384 (91.0) 0.641
  Heart rate >100 bpm 168 (39.6) 171 (40.5) 0.833
  Respiratory rate >24 breaths/min 166 (39.2) 157 (37.2) 0.572
  Systolic blood pressure <90 mm Hg 11 (2.6) 13 (3.1) 0.685
  Hypoxemia 106 (25.0) 113 (26.8) 0.583
  WBC count >11 x 109/L 231 (54.5) 235 (55.7) 0.730
  Altered mental status 9 (2.1) 9 (2.1) 1.000

COPD: chronic obstructive pulmonary disease; BUN: blood urea nitrogen; WBC: white blood cell.